Gene · 11331
Papers2,922
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,922
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies. | Cancer Genet | 2022 | 34974290 | PubTator, text mining | PubMed |
| A pilot study of circulating levels of TGF-β1 and TGF-β2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones. | Bone Rep | 2022 | 34950754 | PubTator, text mining | PubMed |
| Cold plasma surface treatments to prevent biofilm formation in food industries and medical sectors. | Appl Microbiol Biotechnol | 2022 | 34889984 | PubTator, text mining | PubMed |
| Is the bioactivity of induced membranes time dependent? | Eur J Trauma Emerg Surg | 2022 | 34873632 | PubTator, text mining | PubMed |
| Fluorizoline Blocks the Interaction between Prohibitin-2 and γ-Glutamylcyclotransferase and Induces p21Waf1/Cip1 Expression in MCF7 Breast Cancer Cells. | Mol Pharmacol | 2022 | 34862308 | PubTator, text mining | PubMed |
| Divergent effects of sex and calcium/vitamin D supplementation on serum magnesium and markers of bone structure and function during initial military training. | Br J Nutr | 2022 | 34814952 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Advances in the Sensing and Treatment of Wound Biofilms. | Angew Chem Int Ed Engl | 2022 | 34806284 | PubTator, text mining | PubMed |
| Sensitive electrochemical immunosensor to detect prohibitin 2, a potential blood cancer biomarker. | Talanta | 2022 | 34801909 | PubTator, text mining | PubMed |
| AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability. | Autophagy | 2022 | 34798798 | PubTator, text mining | PubMed |
| Global Proteomic Analysis of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells via Connective Tissue Growth Factor Treatment under Chemically Defined Feeder-Free Culture Conditions. | J Microbiol Biotechnol | 2022 | 34750284 | PubTator, text mining | PubMed |
| New Mechanisms and Targets of Subarachnoid Hemorrhage: A Focus on Mitochondria. | Curr Neuropharmacol | 2022 | 34720082 | PubTator, text mining | PubMed |
| Uncovering the 'sphinx' of sphingosine 1-phosphate signalling: from cellular events to organ morphogenesis. | Biol Rev Camb Philos Soc | 2022 | 34585505 | PubTator, text mining | PubMed |
| The multifaceted regulation of mitophagy by endogenous metabolites. | Autophagy | 2022 | 34583624 | PubTator, text mining | PubMed |
| Autophagy-competent mitochondrial translation elongation factor TUFM inhibits caspase-8-mediated apoptosis. | Cell Death Differ | 2022 | 34511600 | PubTator, text mining | PubMed |
| Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae). | Phytochem Rev | 2022 | 34104125 | PubTator, text mining | PubMed |
| A Preliminary Cost-Utility Analysis of the Prosthetic Care Innovations: Case of the Keep Walking Implant. | Can Prosthet Orthot J | 2021 | 37615003 | PubTator, text mining | PubMed |
| Health Service Delivery and Economic Evaluation of Limb Lower Bone-Anchored Prostheses: A Summary of the Queensland Artificial Limb Service's Experience. | Can Prosthet Orthot J | 2021 | 37614998 | PubTator, text mining | PubMed |
| The CORE (Consensus on Relevant Elements) Approach to Determining Initial Core Components of an Innovation. | Front Health Serv | 2021 | 36926486 | PubTator, text mining | PubMed |
| A home-based longitudinal study of vocalization behaviors across infants at low and elevated risk of autism. | Autism Dev Lang Impair | 2021 | 36440373 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11331/papers?page=42